Lymphovascular Invasion is an Independent Negative Prognostic Factor in Esophageal Adenocarcinoma

Background The significance of lymphovascular invasion (LVI) in esophageal adenocarcinoma (EAC) has not yet been described. Potential utility as an adjunct to current staging guidelines remains unknown. Methods The National Cancer Database was queried from 2006 to 2020. Univariate and multivariable models, Kaplan Meier method, and log-rank test were used. Subgroup analyses by pN stage were conducted. Results Of 9,689 patients, 23.2% had LVI. LVI was an independent prognostic factor (hazard ratio [HR] 1.401, 95% confidence interval [CI] 1.307–1.502, p < 0.0001) with reduction in median survival to 20.0 months (95% CI 18.9–21.4) from 39.7 months (95% CI 37.8–42.3, p < 0.0001). Multivariable survival analysis adjusted on pN and pT stage found that patients with LVI had decreased survival in a given pN stage ( p < 0.001). pN0/LVI+ patients had a similar prognosis to the higher staged pN1/LVI− (28.6 months), although pN1/LVI− patients did slightly worse ( p = 0.0135). Additionally, patients with pN1/LVI+ had equivalent survival compared with pN2/LVI− ( p = 0.178) as did pN2/LVI+ patients compared with pN3/LVI− ( p = 0.995). Conclusions In these data, LVI is an independent negative prognostic factor in EAC. LVI was associated with a survival reduction similar to an upstaged nodal status irrespective of T stage. Patients with LVI may be better classified at a higher pN stage.